TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. By Cancer History Project August 6, 2004
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. By Cancer History Project July 30, 2004
TCL Archive Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment By Cancer History Project July 30, 2004
TCL Archive Studies Test New Agents Offering Relief From Treatment-Related Side Effects By Cancer History Project July 30, 2004
TCL Archive Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association. By Cancer History Project July 30, 2004
TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. By Cancer History Project July 30, 2004
TCL Archive Oral UFT Equivalent To FULV In Stage II and III Colon Cancer By Cancer History Project July 30, 2004
TCL Archive Adjuvant Chemo Improves Survival In Early Lung Cancer By Cancer History Project July 30, 2004
Article How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer By Cancer History Project